These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7506655)

  • 1. Plasminogen-activator inhibitor type 2 (PAI-2) is a spontaneously polymerising SERPIN. Biochemical characterisation of the recombinant intracellular and extracellular forms.
    Mikus P; Urano T; Liljeström P; Ny T
    Eur J Biochem; 1993 Dec; 218(3):1071-82. PubMed ID: 7506655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of active human plasminogen activator inhibitor 1 from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells.
    Lawrence D; Strandberg L; Grundström T; Ny T
    Eur J Biochem; 1989 Dec; 186(3):523-33. PubMed ID: 2514093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular polymerization of the serpin plasminogen activator inhibitor type 2.
    Mikus P; Ny T
    J Biol Chem; 1996 Apr; 271(17):10048-53. PubMed ID: 8626560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-function studies of the SERPIN plasminogen activator inhibitor type 1. Analysis of chimeric strained loop mutants.
    Lawrence DA; Strandberg L; Ericson J; Ny T
    J Biol Chem; 1990 Nov; 265(33):20293-301. PubMed ID: 1700786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the binding of urokinase-type plasminogen activator (u-PA) to plasminogen, to plasminogen-activator inhibitor-1 and to the u-PA receptor.
    Lijnen HR; De Cock F; Collen D
    Eur J Biochem; 1994 Sep; 224(2):567-74. PubMed ID: 7925373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitronectin governs the interaction between plasminogen activator inhibitor 1 and tissue-type plasminogen activator.
    Keijer J; Ehrlich HJ; Linders M; Preissner KT; Pannekoek H
    J Biol Chem; 1991 Jun; 266(16):10700-7. PubMed ID: 1709939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and characterization of recombinant porcine plasminogen activator inhibitor-1.
    Bijnens AP; Knockaert I; Cousin E; Kruithof EK; Declerck PJ
    Thromb Haemost; 1997 Feb; 77(2):350-6. PubMed ID: 9157595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A substrate-like form of plasminogen-activator-inhibitor type 1. Conversions between different forms by sodium dodecyl sulphate.
    Urano T; Strandberg L; Johansson LB; Ny T
    Eur J Biochem; 1992 Nov; 209(3):985-92. PubMed ID: 1425706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renaturation, purification, and characterization of human plasminogen activator inhibitor type 2 (PAI-2) accumulated at high level in Escherichia coli.
    Zhou A; Jiang X; Dou F; Zhu D; Xu X
    J Biochem; 1997 May; 121(5):930-4. PubMed ID: 9192735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of serpin specificity by a protein cofactor. Vitronectin endows plasminogen activator inhibitor 1 with thrombin inhibitory properties.
    Ehrlich HJ; Gebbink RK; Keijer J; Linders M; Preissner KT; Pannekoek H
    J Biol Chem; 1990 Aug; 265(22):13029-35. PubMed ID: 1695900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential inhibition of soluble and cell surface receptor-bound single-chain urokinase by plasminogen activator inhibitor type 2. A potential regulatory mechanism.
    Schwartz BS
    J Biol Chem; 1994 Mar; 269(11):8319-23. PubMed ID: 7907591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of recombinant plasminogen activator inhibitor-1 in the active conformation by refolding from inclusion bodies.
    Lee HJ; Im H
    Protein Expr Purif; 2003 Sep; 31(1):99-107. PubMed ID: 12963346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and characterization of active and stable recombinant plasminogen-activator inhibitor accumulated at high levels in Escherichia coli.
    Sancho E; Tonge DW; Hockney RC; Booth NA
    Eur J Biochem; 1994 Aug; 224(1):125-34. PubMed ID: 8076633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction of an RRHR motif into chicken urokinase-type plasminogen activator (ch-uPA) confers sensitivity to plasminogen activator inhibitor (PAI)-1 and PAI-2 and allows ch-uPA-mediated extracellular matrix degradation to be controlled by PAI-1.
    Sipley JD; Alexander DS; Testa JE; Quigley JP
    Proc Natl Acad Sci U S A; 1997 Apr; 94(7):2933-8. PubMed ID: 9096324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of single-chain urokinase and plasminogen activator inhibitor type 1.
    Manchanda N; Schwartz BS
    J Biol Chem; 1995 Aug; 270(34):20032-5. PubMed ID: 7544349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex to the endocytosis receptors alpha2-macroglobulin receptor/low-density lipoprotein receptor-related protein and very-low-density lipoprotein receptor involves basic residues in the inhibitor.
    Rodenburg KW; Kjoller L; Petersen HH; Andreasen PA
    Biochem J; 1998 Jan; 329 ( Pt 1)(Pt 1):55-63. PubMed ID: 9405275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of the complex of plasminogen activator inhibitor type 1 with tissue-type plasminogen activator by mass spectrometry and size-exclusion chromatography.
    Strömqvist M; Karlsson KE; Björquist P; Andersson JO; Byström M; Hansson L; Johansson T; Deinum J
    Biochim Biophys Acta; 1996 Jun; 1295(1):103-9. PubMed ID: 8679667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymerization of plasminogen activator inhibitor-1.
    Zhou A; Faint R; Charlton P; Dafforn TR; Carrell RW; Lomas DA
    J Biol Chem; 2001 Mar; 276(12):9115-22. PubMed ID: 11102455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion of plasminogen activator inhibitor-1 from inhibitor to substrate by point mutations in the reactive-site loop.
    Audenaert AM; Knockaert I; Collen D; Declerck PJ
    J Biol Chem; 1994 Jul; 269(30):19559-64. PubMed ID: 8034724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering plasminogen activator inhibitor 1 mutants with increased functional stability.
    Lawrence DA; Olson ST; Palaniappan S; Ginsburg D
    Biochemistry; 1994 Mar; 33(12):3643-8. PubMed ID: 8142362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.